ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Indexing Info About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

2024, Vol 14, No. 4

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of various integrative fields with Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Publication Advantages in Advanced Pharmaceutical Bulletin are:

Free of charge publication for all types of articles
Fast and constructive peer review
Easy and quick online submission of manuscripts
Author friendly review
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Original Research

1. In Vitro Antioxidant and Anticancer Activity Studies on Drosera Indica L. (Droseraceae)

Raju Asirvatham*, Arockiasamy Josphin Maria Christina, Anita Murali

Adv Pharm Bull. 2013;3(1): 115-120. doi: 10.5681/apb.2013.019

PMCID: PMC3846052 PMID: 24312822 Scopus ID: 84874979894

Article

PDF

XML

Cited By:

Research Article

2. Modulatory Effect of Rutin on the Antitumor Activity and Genotoxicity of Cisplatin in Tumor-Bearing Mice

Rajesh Prasad , Surya Bali Prasad*

Adv Pharm Bull. 2021;11(4): 746-754. doi: 10.34172/apb.2021.084

PMCID: PMC8642793 PMID: 34888222 Scopus ID: 85117163196

Article

PDF

Full Text

XML

Cited By:

Research Article

3. High Sensitivity Troponin T as Complementary Modality for Determining Doxorubicin Regimen Cardiotoxicity in Non-Hodgkin Lymphoma Patients

Ami Ashariati Prayogo* , Satriyo Dwi Suryantoro, Merlyna Savitri, Winona May Hendrata , Andi Yasmin Wijaya , Budi Susetyo Pikir

Adv Pharm Bull. 2022;12(1): 163-168. doi: 10.34172/apb.2022.017

PMCID: PMC9012930 PMID: 35517883 Scopus ID: 85127105583

Article

PDF

Full Text

XML

Cited By:

Review Article

4. The Art of Bioimmunogenomics (BIGs) 5.0 in CAR-T Cell Therapy for Lymphoma Management

Dito Anurogo , Dewi Luthfiana, Nuralfin Anripa , Apriliani Ismi Fauziah, Maratu Soleha, Laila Rahmah, Hana Ratnawati, Teresa Liliana Wargasetia, Sari Eka Pratiwi, Riswal Nafi Siregar, Ratis Nour Sholichah, Muhammad Sobri Maulana , Taruna Ikrar*, Yu Hsiang Chang, Jiantai Timothy Qiu*

Adv Pharm Bull. 2024;14(2): 314-330. doi: 10.34172/apb.2024.034

PMCID: PMC11347730 PMID: 39206402

Article

PDF

Full Text

XML

Cited By: